Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Aug;76(2):426-30.
doi: 10.1172/JCI111989.

Evidence for a mouse mesangial cell-derived factor that stimulates lymphocyte proliferation

Evidence for a mouse mesangial cell-derived factor that stimulates lymphocyte proliferation

E P MacCarthy et al. J Clin Invest. 1985 Aug.

Abstract

The functions of the glomerular mesangium are served by at least two populations of cells--a cell bearing microfilaments that regulates blood flow, and a phagocytic cell bearing Ia determinants and Fc receptors. We provide evidence that mouse mesangial cells (bearing microfilaments) produce a factor(s) that stimulates spleen cell proliferation. The factor(s) appears to act via monocytes/macrophages, since its stimulatory activity is abrogated by prior depletion of the responding mononuclear cell population of monocytes/macrophages. Confirmation of its action on macrophages was documented by experiments that showed that medium from macrophages incubated with mesangial cell supernatant contained greater amounts of a factor that stimulated [3H]thymidine uptake by macrophage-depleted spleen cell populations. By the cothymocyte proliferation assay, it could be shown that mesangial cell supernatant induced splenic macrophage production of interleukin-1-like activity. Preliminary characterization reveals the factor to have a molecular weight greater than 100,000. Thus, a novel function is delineated for this mesangial cell type that appears capable of modulating the local immune response by providing an amplification signal.

PubMed Disclaimer

References

    1. J Immunol Methods. 1974 Aug;5(3):239-47 - PubMed
    1. J Immunol. 1984 Sep;133(3):1346-9 - PubMed
    1. FEBS Lett. 1979 Aug 15;104(2):420-4 - PubMed
    1. J Exp Med. 1979 Sep 19;150(3):413-25 - PubMed
    1. J Clin Invest. 1980 Mar;65(3):754-60 - PubMed

Publication types